Literature DB >> 15049015

Staged informed consent for a randomized clinical trial in childhood leukemia: impact on the consent process.

A L Angiolillo1, C Simon, E Kodish, B Lange, R B Noll, K Ruccione, Y Matloub.   

Abstract

BACKGROUND: Children Cancer Group (CCG) 1991 is the first childhood acute lymphoblastic leukemia trial within CCG that allowed the utilization of a staged approach to the consent process.
METHODS: One hundred and forty subjects participated in the Project on Informed Consent which compared the primary outcome measures in the consent process of patients enrolled in CCG-1991 with those enrolled in other CCG leukemia studies.
RESULTS: The parents' trust scores were higher for the CCG-1991 compared with other protocols. Eighty percent of parents enrolled in CCG-1991 understood the distinction between the randomized clinical trial and the standard treatment arm, compared with 62.5% in the other studies, P = 0.05. Multiple other outcome measures suggested a positive impact from staged informed consent.
CONCLUSIONS: Our results suggest that a consent process with a staged approach can help investigators obtain a more truly informed consent. Future research is needed to confirm the benefits of the staged approach to the informed consent process. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  2004        PMID: 15049015     DOI: 10.1002/pbc.20010

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  16 in total

1.  Stem cell clinical trials for spinal cord injury: readiness, reluctance, redefinition.

Authors:  J Illes; J C Reimer; B K Kwon
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

2.  Inclusion of children in the initial conversation about their cancer diagnosis: impact on parent experiences of the communication process.

Authors:  Sarah R Brand McCarthy; Tammy I Kang; Jennifer W Mack
Journal:  Support Care Cancer       Date:  2019-01-23       Impact factor: 3.603

3.  Ethical challenges in conducting clinical research in lung cancer.

Authors:  Peter Allmark; Angela M Tod
Journal:  Transl Lung Cancer Res       Date:  2016-06

Review 4.  Recommendations for enhancing clinical trials education: a review of the literature.

Authors:  Karen A Stepan; Amy P Gonzalez; Vivian S Dorsey; Debra K Frye; Nita D Pyle; Regina F Smith; Terry A Throckmorton; Louise A Villejo; Scott B Cantor
Journal:  J Cancer Educ       Date:  2011-03       Impact factor: 2.037

Review 5.  Proposals to Conduct Randomized Controlled Trials Without Informed Consent: a Narrative Review.

Authors:  James H Flory; Alvin I Mushlin; Zachary I Goodman
Journal:  J Gen Intern Med       Date:  2016-07-06       Impact factor: 5.128

6.  Communicating and understanding the purpose of pediatric phase I cancer trials.

Authors:  Melissa K Cousino; Stephen J Zyzanski; Amy D Yamokoski; Rebecca A Hazen; Justin N Baker; Robert B Noll; Susan R Rheingold; J Russell Geyer; Stewart C Alexander; Dennis Drotar; Eric D Kodish
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

7.  Ethical issues in health research in children.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-10       Impact factor: 2.253

8.  Models of consent to return of incidental findings in genomic research.

Authors:  Paul S Appelbaum; Erik Parens; Cameron R Waldman; Robert Klitzman; Abby Fyer; Josue Martinez; W Nicholson Price; Wendy K Chung
Journal:  Hastings Cent Rep       Date:  2014-06-11       Impact factor: 2.683

9.  Parental decision making regarding consent to randomization on Children's Oncology Group AALL0932.

Authors:  Kellee Parker; Erika Cottrell; Linda Stork; Susan Lindemulder
Journal:  Pediatr Blood Cancer       Date:  2021-01-26       Impact factor: 3.167

Review 10.  Decision aids for people considering taking part in clinical trials.

Authors:  Katie Gillies; Seonaidh C Cotton; Jamie C Brehaut; Mary C Politi; Zoe Skea
Journal:  Cochrane Database Syst Rev       Date:  2015-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.